Could cannabinoid biosynthesis be the next big thing for investors?

Could cannabinoid biosynthesis be the next big thing for investors?

Legalisation, increasing acceptance and growing demand for pharmaceutical and consumer products mean the cannabinoids (CBD) industry is booming. Will biosynthesis take it to new heights?

This is the CBD conversation you won’t want to miss.

Latest

Demand for Teslas points to lithium deficit

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free